Recombinant SARS-CoV-2 Spike anticorps (RBD)
Aperçu rapide pour Recombinant SARS-CoV-2 Spike anticorps (RBD) (ABIN7482298)
Antigène
Voir toutes SARS-CoV-2 Spike AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- RBD
-
Fonction
- Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 (2G7F5) (MALS verified)
-
Attributs du produit
- Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Spike protein.
-
Immunogène
- Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Spike protein.
-
Isotype
- IgG1
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Stock
- -20 °C
-
-
- SARS-CoV-2 Spike
-
Autre désignation
- SARS-CoV-2 Spike protein
-
Classe de substances
- Viral Protein
-
Sujet
- It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Antigène
-